perfosfamide has been researched along with Complication, Postoperative in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berman, E; Clarkson, B; Cunningham, I; Flomenberg, N; Gee, T; Gulati, SC; O'Reilly, RJ; Sarris, A; Shank, B | 1 |
| Colvin, M; Mangan, KF; Przepiorka, D; Rosenfeld, C; Shadduck, RK | 1 |
| Beschorner, WE; Braine, HG; Brookmeyer, R; Burns, WH; Fuller, DJ; Kaizer, H; Korbling, M; Mangan, KF; Saral, R; Stuart, RK | 1 |
1 trial(s) available for perfosfamide and Complication, Postoperative
| Article | Year |
|---|---|
Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; In Vitro Techniques; Leukemia; Leukopenia; Male; Middle Aged; Postoperative Complications; Transplantation, Autologous | 1985 |
2 other study(ies) available for perfosfamide and Complication, Postoperative
| Article | Year |
|---|---|
Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Etoposide; Evaluation Studies as Topic; Freezing; Humans; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Organ Preservation; Postoperative Complications; Preoperative Care; Transplantation, Autologous | 1989 |
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in late remission or early relapse.
Topics: Actuarial Analysis; Adult; Blood Cell Count; Bone Marrow; Bone Marrow Transplantation; Child; Cyclophosphamide; Female; Graft Rejection; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Postoperative Complications; Recurrence; Remission Induction; Transplantation, Autologous | 1989 |